Management of adult syphilis

Clinical Infectious Diseases

Volumn 53, Issue SUPPL. 3, 2011, Pages

  Ghanem, Khalil G ^a   Workowski, Kimberly A ^b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BENZATHINE PENICILLIN; CEFTRIAXONE; DOXYCYCLINE; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; PROBENECID; PROCAINE PENICILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIBODY TITER; BACTERIAL MUTATION; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID EXAMINATION; DRUG CHOICE; DRUG EFFICACY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUROSYPHILIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REAGIN TEST; REVIEW; SINGLE DRUG DOSE; SYPHILIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREPONEMA PALLIDUM;

ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID; DRUG RESISTANCE, BACTERIAL; HIV INFECTIONS; HUMANS; LEUKOCYTOSIS; PENICILLIN G BENZATHINE; PRACTICE GUIDELINES AS TOPIC; SEROLOGIC TESTS; SYPHILIS; TREATMENT OUTCOME;

EID: 81055133523     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir701     Document Type: Review

References (74)

1. Centers for Disease Control and Prevention. Sexually transmitted diseases surveillance, 2008. Atlanta, GA: US Department of Health and Human Services, 2009.
2. Dowell D, Polgreen PM, Beekmann SE, Workowski KA, Berman SM, Peterman TA. Dilemmas in the management of syphilis: a survey of infectious diseases experts. Clin Infect Dis 2009; 49:1526-9.
3. Gross PA. When guidelines don't guide the physician. Clin Infect Dis 2009; 49:1530-1.
4. Hook EW 3rd, Behets F, Van Damme K, et al. A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis. J Infect Dis 2010; 201:1729-35.
5. Bai ZG, Yang KH, Liu YL, et al. Azithromycin vs. benzathine penicillin G for early syphilis: a meta-analysis of randomized clinical trials. Int J STD AIDS 2008; 19:217-21.
6. Riedner G, Rusizoka M, Todd J, et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl JMed 2005; 353:1236-44. (Pubitemid 41345945)
7. Kiddugavu MG, Kiwanuka N, Wawer MJ, et al. Effectiveness of syphilis treatment using azithromycin and/or benzathine penicillin in Rakai, Uganda. Sex Transm Dis 2005; 32:1-6. (Pubitemid 40054154)
8. Toutous-Trellu L, Gayet-Ageron A, Ninet B, Piguet V, Schrenzel J. Frequent resistance of Treponema pallidum to azithromycin in Geneva. In: 48th Annual Intersciences Conference on Antimicrobial Agents and Chemotherapy and Infectious Diseases Society of America 46th Annual Meeting; 25-28 October 2008; Washington, DC: ICAAC/IDSA, 2008.
9. Katz KA, Ahrens K, Engelman J, Godornes C, Lukehart S, Klausner J. Increasing rate of azithromycin resistance in Treponema pallidum infections: San Francisco, 2005-2006. In: 2008 National STD Prevention Conference; 10-13 March 2008. Chicago, IL: Centers for Disease Control and Prevention, 2008.
10. Pandori MW, Gordones C, Castro L, et al. Detection of azithromycin resistance in Treponema pallidum by real-time PCR. Antimicrob Agents Chemother 2007; 51:3425-30. (Pubitemid 350067571)
11. Marra CM, Colina AP, Godornes C, et al. Antibiotic selection may contribute to increases in macrolide-resistant Treponema pallidum. J Infect Dis 2006; 194:1771-3. (Pubitemid 44902010)
12. Mitchell SJ, Engelman J, KentCK, Lukehart SA, Godornes C, Klausner JD. Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004. Clin Infect Dis 2006; 42:337-45. (Pubitemid 43122308)
13. Morshed MG, Jones HD. Treponema pallidum macrolide resistance in BC. CMAJ 2006; 174:349.
14. Zhou P, Qian Y, Xu J, Gu Z, Liao K. Occurrence of congenital syphilis after maternal treatment with azithromycin during pregnancy. Sex Transm Dis 2007; 34:472-4. (Pubitemid 46987953)
15. Spooner K, Barthel RV, Robertson J, et al. Azithromcyin might not protect against Treponema pallidum infection or reactivation in HIV type 1-infected patients. Clin Infect Dis 2005; 41:419-20.
16. Wong T, Singh AE, De P. Primary syphilis: serological treatment response to doxycycline/tetracycline versus benzathine penicillin. Am J Med 2008; 121:903-8.
17. Ghanem KG, Erbelding EJ, Cheng WW, Rompalo AM. Doxycycline compared with benzathine penicillin for the treatment of early syphilis. Clin Infect Dis 2006; 42:e45-9.
18. Zhou P, Gu Z, Xu J, Wang X, Liao K. A study evaluating ceftriaxone as a treatment agent for primary and secondary syphilis in pregnancy. Sex Transm Dis 2005; 32:495-8. (Pubitemid 41060390)
19. Gutierrez-Galhardo MC, do Valle GF, Sa FC, Schubach Ade O, do Valle AC. Clinical characteristics and evolution of syphilis in 24 HIV1 individuals in Rio de Janeiro, Brazil. Rev Inst Med Trop Sao Paulo 2005; 47:153-7. (Pubitemid 40917009)
20. Ghanem KG, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA. Lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms. Clin Infect Dis 2009; 48:816-21.
21. Wang L-, Zuo Y-, Liu Y-, Liu X-, Zheng H-. Incidence of seroresistance of syphilis and its relevant factors. Acta Acad Med Sin 2008; 30:338-41.
22. Carpenter T, Malik F, Lazzaro D, Lazzaro E, Augenbraun M. Clinical ophthalmologic findings and syphilis serology poorly predict neurosyphilis [abstract L-652]. In: 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and Infectious Diseases Society of America 46th Annual Meeting. ICAAC/IDSA, 2008.
23. Thng C, Poluri R, Komolafe A, Ratcliffe L, Javier V, Higgins S. Use of lumbar puncture in the management of patients with early syphilis [abstract B-22]. In: British Association of Sexual Health and HIV and the American Sexually Transmitted Diseases Association Third Joint Conference. BASHH/ASTDA, 2008.
24. Taylor MM, Aynalem G, Olea LM, He P, Smith LV, Kerndt PR. A consequence of the syphilis epidemic among men who have sex with men (MSM): neurosyphilis in Los Angeles, 2001-2004. Sex Transm Dis 2008; 35:430-4. (Pubitemid 351670543)
25. Libois A, De Wit S, Poll B, et al. HIV and syphilis: when to perform a lumbar puncture. Sex Transm Dis 2007; 34:141-4. (Pubitemid 46673215)
26. Marra CM, Maxwell CL, Tantalo LC, Sahi SK, Lukehart SA. Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis. Clin Infect Dis 2008; 47:893-9.
27. McClelland RS, Lavreys L, Katingima C, et al. Contribution of HIV-1 infection to acquisition of sexually transmitted disease: a 10-year prospective study. J Infect Dis 2005; 191:333-8. (Pubitemid 40139757)
28. Branger J, van der Meer JT, van Ketel RJ, Jurriaans S, Prins JM. High incidence of asymptomatic syphilis in HIV-infected MSM justifies routine screening. Sex Transm Dis 2009; 36:84-5.
29. Cohen CE, Winston A, Asboe D, et al. Increasing detection of asymptomatic syphilis in HIV patients. Sex Transm Infect 2005; 81:217-9. (Pubitemid 40835046)
30. Ghanem KG, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA. Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients. Clin Infect Dis 2008; 47:258-65. (Pubitemid 351920630)
31. Ghanem KG, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA. Neurosyphilis in a clinical cohort of HIV-1-infected patients. AIDS 2008; 22:1145-51.
32. Cicconi P, Cozzi-Lepri A, Orlando G, et al. Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis. Infection 2008; 36:46-53.
33. Park WB, Jang HC, Kim SH, et al. Effect of highly active antiretroviral therapy on incidence of early syphilis in HIV-infected patients. Sex Transm Dis 2008; 35:304-6. (Pubitemid 351619535)
34. Warwick Z, Dean G, Fisher M. Should syphilis be treated differently in HIV-positive and HIV-negative individuals? Treatment outcomes at a university hospital, Brighton, UK. Int J STD AIDS 2009; 20: 229-30.
35. Poliseli R, Vidal JE, De Oliveira ACP, Hernandez AV. Neurosyphilis in HIV-infected patients: clinical manifestations, serum venereal disease research laboratory titers, and associated factors to symptomatic neurosyphilis. Sex Transm Dis 2008; 35:425-9. (Pubitemid 351670542)
36. Mishra S, Walmsley SL, Loutfy MR, Kaul R, Logue KJ, Gold WL. Otosyphilis in HIV-coinfected individuals: a case series from Toronto, Canada. AIDS Patient Care STDS 2008; 22:213-9. (Pubitemid 351380154)
37. Manavi K, McMillan A. The outcome of treatment of early latent syphilis and syphilis with undetermined duration in HIV-infected and HIV-uninfected patients. Int J STD AIDS 2007; 18:814-8. (Pubitemid 351738858)
38. Ghanem KG, Erbelding EJ, Wiener ZS, Rompalo AM. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Infect 2007; 83:97-101. (Pubitemid 46713595)
39. Balba GP, Kumar PN, James AN, et al. Ocular syphilis in HIV-positive patients receiving highly active antiretroviral therapy. Am J Med 2006; 119:448.e21-5.
40. Kofoed K, Gerstoft J, Mathiesen LR, Benfield T. Syphilis and human immunodeficiency virus (HIV)-1 coinfection: influence on CD4 T-cell count, HIV-1 viral load, and treatment response. Sex Transm Dis 2006; 33:143-8. (Pubitemid 43790821)
41. Long CM, Klausner JD, Leon S, et al. Syphilis treatment and HIV infection in a population-based study of persons at high risk for sexually transmitted disease/HIV infection in Lima, Peru. Sex Transm Dis 2006; 33:151-5. (Pubitemid 43790823)
42. Walter T, Lebouche B, Miailhes P, et al. Symptomatic relapse of neurologic syphilis after benzathine penicillin G therapy for primary or secondary syphilis in HIV-infected patients. Clin Infect Dis 2006; 43:787-90. (Pubitemid 44330747)
43. Abraham B, Marih L, Thevenet S, et al. Outbreak of syphilis among HIV-infected patients: descriptive data from a Parisian hospital. Sex Transm Dis 2005; 32:718-9. (Pubitemid 41682160)
44. Palacios R, Jimenez-Onate F, Aguilar M, et al. Impact of syphilis infection on HIV viral load and CD4 cell counts in HIV-infected patients. J Acquir Immune Defic Syndr 2007; 44:356-9. (Pubitemid 46328355)
45. Mwapasa V, Rogerson SJ, Kwiek JJ, et al. Maternal syphilis infection is associated with increased risk of mother-to-child transmission of HIV in Malawi. AIDS 2006; 20:1869-77. (Pubitemid 44358905)
46. Sadiq ST, McSorley J, Copas AJ, et al. The effects of early syphilis on CD4 counts and HIV-1 RNA viral loads in blood and semen. Sex Transm Infect 2005; 81:380-5. (Pubitemid 41494351)
47. Centers for Disease Control and Prevention (CDC). Syphilis testing algorithms using treponemal tests for initial screening-four labora-tories, New York City, 2005-2006. MMWR Morb Mortal Wkly Rep 2008; 57:872-5.
48. Singh AE, Wong T, De P. Characteristics of primary and late latent syphilis cases which were initially non-reactive with the rapid plasma reagin as the screening test. Int J STD AIDS 2008; 19:464-8.
49. Chuck A, Ohinmaa A, Tilley P, Singh A, Jacobs P. Cost effectiveness of enzyme immunoassay and immunoblot testing for the diagnosis of syphilis. Int J STD AIDS 2008; 19:393-9.
50. Augenbraun M, Abu-Lawi K, Phillips S. Discordant ELISA and RPR tests for syphilis in HIV infected and uninfected individuals. In: 17th International Society for STD research; 29 July to 1 August 2007; Seattle, WA: International Society for Sexually Transmitted Diseases Research. 2007.
51. Woehrl S, Geusau A. Neurosyphilis is unlikely in patients with late latent syphilis and a negative blood VDRL test. Acta Derm Venereol 2006; 86:335-9. (Pubitemid 44133381)
52. Hook EW 3rd, Martin DH, Stephens J, Smith BS, Smith K. A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex Transm Dis 2002; 29:486-90. (Pubitemid 34851786)
53. Katz KA, Klausner JD. Azithromycin resistance in Treponema pallidum. Curr Opin Infect Dis 2008; 21:83-91.
54. Martin IE, Tsang RS, Sutherland K, et al. Molecular characterization of syphilis in patients in Canada: azithromycin resistance and detection of Treponema pallidum DNA in whole-blood samples versus ulcerative swabs. J Clin Microbiol 2009; 47:1668-73.
55. Martin IE, Gu W, Yang Y, Tsang RS. Macrolide resistance and molecular types of Treponema pallidum causing primary syphilis in Shanghai, China. Clin Infect Dis 2009; 49:515-21.
56. Lukehart SA, Godornes C, Molini BJ, et al. Macrolide resistance in Treponema pallidum in the united states and Ireland. N Engl J Med 2004; 351:154-8.
57. Van Damme K, Behets F, Ravelomanana N, et al. Evaluation of azithromycin resistance in Treponema pallidum specimens from Madagascar. Sex Transm Dis 2009; 36:775-6.
58. Su J, Hook E, Kenney K, et al. Prevalence of the 23S rRNA point mutation in Treponema pallidum in the United States and associated factors, 2006-2008. In: 18th International Society for STD research; 28 June to 1 July 2009. London, United Kingdom, 2009.
59. Hook EW 3rd, Roddy RE, Handsfield HH. Ceftriaxone therapy for incubating and early syphilis. J Infect Dis 1988; 158:881-4.
60. Cuddy PG. Benzathine penicillin G in the treatment of neurosyphilis. Drug Intell Clin Pharm 1982; 16:205-10. (Pubitemid 12155668)
61. Mohr JA, Griffiths W, Jackson R, Saadah H, Bird P, Riddle J. Neurosyphilis and penicillin levels in cerebrospinal fluid. JAMA 1976; 236:2208-9.
62. Smith CA, Kamp M, Olansky S, Price EV. Benzathine penicillin G in the treatment of syphilis. Bull World Health Organ 1956; 15:1087-96.
63. Idsoe O, Guthe T, Willcox RR. Penicillin in the treatment of syphilis: the experience of three decades. Bull World Health Organ 1972; 47:1-68.
64. de Gracianski P, Grupper C. Results of the treatment of primosecondary syphilis with a single injection of long-acting depot penicillin: apropos of 147 cases. Sem Hop 1960; 36:1441-50.
65. Schroeter AL, Lucas JB, Price EV, Falcone VH. Treatment for early syphilis and reactivity of serologic tests. JAMA 1972; 221:471-6.
66. Rolfs RT, Joesoef MR, Hendershot EF, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. the syphilis and HIV study group. N Engl J Med 1997; 337:307-14. (Pubitemid 27318992)
67. Moore JE, Padget P. The problem of seroresistant syphilis (so-called Wassermann fastness). J Am Med Assoc 1938; 110:96-100.
68. Marra CM, Maxwell CL, Smith SL, et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004; 189:369-76. (Pubitemid 38210572)
69. Marra CM, Maxwell CL, Collier AC, Robertson KR, Imrie A. Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy. BMC Infect Dis 2007; 7:37.
70. Marra CM, Longstreth WT Jr, Maxwell CL, Lukehart SA. Resolution of serum and cerebrospinal fluid abnormalities after treatment of neurosyphilis. influence of concomitant human immunodeficiency virus infection. Sex Transm Dis 1996; 23:184-9. (Pubitemid 26156242)
71. Moore JE. Studies in asymptomatic neurosyphilis. II. The classification, treatment, and prognosis of early asymptomatic neurosyphilis. Bull Johns Hopkins Hosp 1922; 33:231-46.
72. Moore JE, Hopkins HH. Asymptomatic neurosyphilis. VI. The prognosis of early and late asymptomatic neurosyphilis. J Am Med Assoc 1930; 95:1637-41.
73. Centers for Disease Control and Prevention (CDC). Symptomatic early neurosyphilis among HIV-positive men who have sex with men-four cities, United States, January 2002-June 2004. MMWR Morb Mortal Wkly Rep 2007; 56:625-8.
74. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Service, 2011; 1-166. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.